Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 08, 2026
SMJ International Holdings (SMJF) Climbs +54% in 30 Days as Low Float and Governance Shift Attract Attention

SMJ International Holdings (SMJF) Climbs +54% in 30 Days as Low Float and Governance Shift Attract Attention

Key Takeaways

  • SMJ International Holdings (SMJF) surged approximately 54% over the last 30 days, climbing from $5.41 on July 9 to $8.35 as of August 7, 2026.
  • The most dramatic upward move occurred between August 5 and August 7, when shares rallied from $5.58 to $8.35 in just three trading sessions on sharply elevated volume.
  • A low public float of roughly 2.7 million shares has made SMJF highly susceptible to outsized price swings on relatively modest trading activity.
  • The company called an extraordinary general meeting for September 15, 2026, to vote on governance changes including revised Class B share conversion triggers — a development that drew fresh investor attention.
  • Over the broader quarter, SMJF has rallied approximately 145% from around $3.41 in mid-May, reflecting sustained speculative interest in this recently listed small-cap flooring specialist.

SMJ International Holdings (SMJF): Company Snapshot and Positioning

SMJ International Holdings Inc. is a Singapore-based premier flooring specialist founded in 1988. The company designs, sells, and distributes a wide range of flooring products — including carpet tiles, broadloom carpets, and vinyl tiles — under its proprietary "SMJ" brand. Its core customer base spans property developers, architecture and interior design firms, and commercial space owners across more than 20 markets, primarily in Asia. SMJ also supplies environmentally certified flooring solutions aligned with government-led sustainable building initiatives throughout the region. The company completed its initial public offering on December 4, 2025, listing on the NYSE American at $4.00 per share under the ticker SMJF, raising approximately $10.8 million in gross proceeds. With a dual-class share structure and a market capitalization of roughly $157 million as of early August 2026, SMJF is a small-cap name that has attracted attention for its niche positioning in Asia's commercial flooring market and its unusually volatile trading patterns since its debut.

SMJ International Holdings (SMJF) Stock Performance: 30-Day Move Versus the Quarter

Over the last 30 days, SMJF delivered a gain of approximately 54%, rising from a closing price of $5.41 on July 9, 2026, to $8.35 on August 7, 2026. The rally accelerated sharply in the final three trading sessions of the period: shares closed at $5.58 on August 4 before leaping to $6.75 on August 5, surging another 21.5% to $8.20 on August 6, and adding a further 1.8% to reach $8.35 on August 7. Daily trading volume during this three-day burst averaged well over 1 million shares, far exceeding the stock's three-month average of roughly 745,000. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Zooming out to the last quarter, the performance is even more dramatic. In mid-May 2026, SMJF was trading around $3.41, meaning the stock has appreciated roughly 145% over approximately three months. This multi-month uptrend featured several distinct rallies — including a strong move in late May and another in June — punctuated by periodic pullbacks, before the early August spike pushed shares to new all-time highs above the $8.00 threshold.

Factors Behind the Recent 30-Day Advance in SMJF Shares

Several converging factors explain the extraordinary 30-day move in SMJF shares. On July 28, the company filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2026, reporting revenue of SGD 17.44 million (up 3.6% year-over-year) alongside a net loss of SGD 0.93 million, a reversal from the prior year's SGD 1.02 million profit. While the bottom-line swing into losses might normally weigh on a stock, the filing appeared to reignite trading interest in the thinly traded name.

Then, in early August, SMJ International announced an extraordinary general meeting (EGM) scheduled for September 15, 2026, at which shareholders will vote on amendments to the company's constitutional documents. The proposed changes include modifying automatic conversion triggers for high-vote Class B shares — including the removal of provisions that previously triggered conversion upon a director's resignation or a Class B holder's death — as well as lowering the written resolution approval threshold to two-thirds of voting rights. For a company with a dual-class structure where Class B shares carry 10 votes each, governance changes of this nature carry significant implications for control dynamics, and the announcement appeared to catalyze a wave of speculative buying.

Critically, SMJF's extremely small public float — estimated at approximately 2.7 million shares — acts as a powerful amplifier for any directional move. With insiders holding roughly 27% of shares and institutional ownership at just 3.7%, the freely traded supply is minimal, meaning even moderate buying pressure can trigger outsized price swings. By August 7, the stock had registered on multiple screens as one of the most overbought names based on its 14-day Relative Strength Index, confirming the intensity of the rally.

Quarterly Drivers Behind SMJF’s Broader Advance

The broader quarterly trend in SMJF reflects a pattern that has characterized the stock since its December 2025 IPO: extended periods of low-volume consolidation punctuated by sharp, high-volume rallies. After trading down to approximately $3.41 in mid-May, the stock caught a bid that carried it above $5.00 by late May, supported by heightened trading volumes. A second leg higher in June pushed shares to the $5.30–$5.50 range, where they consolidated for several weeks before the early August breakout.

Throughout this period, the company's fundamentals showed a mixed picture. Revenue grew modestly, but rising selling, general, and administrative expenses — which jumped from SGD 3.79 million in FY2025 to SGD 5.87 million in FY2026 — drove the swing to an operating loss. Free cash flow turned deeply negative at negative SGD 3.47 million. Despite these headwinds, the stock's low-float dynamics and governance-related catalysts have consistently attracted momentum-driven trading interest. Additionally, SMJF previously experienced unusual market activity in February 2026, at which time the company stated it was unaware of any undisclosed material information to explain the volatility — a pattern that has now repeated in even more dramatic fashion. From what I see, the low-float environment continues to play a central role here.

SMJF Stock Forecast Drivers: What to Monitor Going Forward

Looking ahead, the September 15 extraordinary general meeting stands as the most immediate catalyst for SMJF. The outcome of the vote on governance amendments — particularly changes to Class B share conversion rules — could materially affect the balance of voting power between insiders and public shareholders. Investors should also monitor whether the company provides any updated financial guidance or strategic direction alongside the EGM.

Beyond the governance vote, SMJF's fundamental trajectory warrants close attention. The company's FY2026 results showed declining profitability and negative free cash flow, raising questions about the sustainability of its current valuation. The stock trades at a price-to-sales ratio above 10 and a price-to-book ratio above 10 — elevated multiples for a small-cap building materials distributor with negative earnings. Additionally, the extremely low float means liquidity risk remains acute: sharp reversals are as possible as sharp rallies, and the stock's history of unusual trading activity underscores the importance of cautious position sizing. Macroeconomic conditions in Asian real estate markets, where SMJF derives substantially all its revenue, will also influence demand for commercial flooring products in the quarters ahead. I’m watching this closely as the EGM approaches.

Using Tickeron AI Tools for Fast-Moving Names

In my view, tools like Tickeron’s Trending AI Robots provide a practical way to review automated strategies that have performed well in volatile conditions. The platform features hundreds of AI-powered trading robots across different timeframes and risk profiles, highlighting those with standout recent results. This helps when evaluating names that move quickly on low volume, offering another lens on potential momentum without replacing core fundamental review.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SMJF

Contributor

<p>Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years&nbsp;developing&nbsp;his proprietary trading and quantitative algorithms (now Tickeron&rsquo;s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional,&nbsp;sophisticated stock market analysis capabilities to retail investors via&nbsp;an easy-to-use interface.</p>


SMJF's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for SMJF turned positive on July 23, 2026. Looking at past instances where SMJF's MACD turned positive, the stock continued to rise in of 3 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 21, 2026. You may want to consider a long position or call options on SMJF as a result. In of 8 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where SMJF advanced for three days, in of 37 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 14 cases where SMJF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SMJF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SMJF broke above its upper Bollinger Band on August 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SMJF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: SMJF's P/B Ratio (15.674) is slightly higher than the industry average of (4.390). P/E Ratio (218.351) is within average values for comparable stocks, (122.755). SMJF's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (6.657). SMJF's Dividend Yield (0.000) is considerably lower than the industry average of (0.018). SMJF's P/S Ratio (15.873) is slightly higher than the industry average of (3.656).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SMJF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.

Industry description

The textiles industry includes companies that spin fiber and weave fabrics into raw products such as polyester filaments and staple yarns that are manufactured into finished products. Albany International Corp., Unifi, Inc. and Culp, Inc. are some of the major players in this business.

Market Cap

The average market capitalization across the Textiles Industry is 440.94M. The market cap for tickers in the group ranges from 1.12K to 10.82B. TRYIF holds the highest valuation in this group at 10.82B. The lowest valued company is UNIR at 1.12K.

High and low price notable news

The average weekly price growth across all stocks in the Textiles Industry was 10%. For the same Industry, the average monthly price growth was 15%, and the average quarterly price growth was 20%. SMJF experienced the highest price growth at 47%, while AIN experienced the biggest fall at -16%.

Volume

The average weekly volume growth across all stocks in the Textiles Industry was 58%. For the same stocks of the Industry, the average monthly volume growth was 337% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 73
P/E Growth Rating: 65
Price Growth Rating: 53
SMR Rating: 78
Profit Risk Rating: 100
Seasonality Score: 8 (-100 ... +100)
View a ticker or compare two or three
SMJF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Textiles

Profile
Details
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.